Ansa Biotechnologies is located in Berkeley. If you are interested in joining us on our mission to enable the next generation of DNA synthesis, please contact us.

We are currently looking for an automation engineer with experience in microfluidics / digital microfluidics and for a chemist with experience synthesizing dNTP analogs.


Daniel Arlow, CEO

PhD, UC Berkeley

Dan has been a member of Jay Keasling's lab at UC Berkeley and Lawrence Berkeley Laboratory since 2013, where he has focused on the development of new technologies for the synthesis of DNA. Previously, Dan was a Scientific Associate at D.E. Shaw Research, LLC, where he studied the biophysical properties of    G protein-coupled receptors, including how drugs bind to and modulate their activity. Dan has dual S.B. degrees in Math with Computer Science and Biology from MIT, and will receive his PhD in Biophysics from UC Berkeley in 2018. He has co-authored over 20 scientific publications, including papers in Nature, Science, Cell, PNAS, and Nature Biotechnology that have been cited over 5,000 times in aggregate, and is a co-inventor of two patents.

856774_10102836147978590_447510674_o.jpg

2018-06-08-portraits-sebastian-018.jpg

Sebastian Palluk, CTO

PHd student, TU Darmstadt

Sebastian received a Bachelor's degree in Biology and a Master's degree in Biomolecular Engineering from Darmstadt University of Technology. His Master's thesis research was a computational investigation of the compatibility of Terminal Deoxynucleotidyl Transferase (TdT) with reversible Terminator Nucleotides (RTdNTPs) for de novo DNA synthesis. Sebastian joined Lawrence Berkeley Lab's Joint BioEnergy Institute in 2015, where he teamed up with Dan to develop the first demonstration of a practical enzymatic de novo DNA synthesis method, reported in Nature Biotechnology.